| 書目名稱 | Heart Failure | | 副標題 | Frontiers in Cardiol | | 編輯 | Akira Kitabatake (Director and Chairman),Shigetake | | 視頻video | http://file.papertrans.cn/425/424926/424926.mp4 | | 概述 | Providing a wide range of works from molecular pathophysiology to surgical treatment | | 圖書封面 |  | | 描述 | Remarkable progress has been made in understanding and treating heart failure. Among other developments, angiotensin-converting enzyme inhibitors and b blockers have been found to have beneficial therapeutic effects, reinforcing the view that heart failure may be both a hemodynamic and a neurohumoral disorder. The Japanese Heart Failure Society was established to curb the threat of heart failure through research, education, and clinical practice. At the Societys 2nd Annual Scientific Meeting in Sapporo, molecular biologists, physiologists, clinicians, surgeons, and researchers in related fields met to strengthen professional bonds for the ultimate goal of preventing death from heart failure. This book contains presentations from the Sapporo conference that provide new insights into heart failure in the areas of pathophysiology, cardiac sudden death, medical and surgical treatment, and promising new gene therapy. | | 出版日期 | Conference proceedings 2000 | | 關鍵詞 | Angiotensin II; Arrhythmias; Beyond ACE Inhibitors; Beyond Cardiac Transplantation; Gene Therapy; Heart F | | 版次 | 1 | | doi | https://doi.org/10.1007/978-4-431-68331-5 | | isbn_softcover | 978-4-431-68333-9 | | isbn_ebook | 978-4-431-68331-5 | | copyright | Springer-Verlag Tokyo 2000 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-14 16:35
發(fā)表于 2025-3-21 18:38:50
